Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 96101-96150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04771130
A Study of BGB-11417 in Participants With Myeloid Malignancies
PHASE1/PHASE2Recruiting
260 participants
Started: May 24, 2021 · Completed: Feb 8, 2028
3 conditions1 sponsor49 locations
NCT04259788
An AHEI Dietary Intervention to Reduce Pain in Women With Endometriosis
NAActive, not recruiting
109 participants
Started: May 24, 2021 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05127265
Pervasive Sensing and AI in Intelligent ICU
N/ARecruiting
400 participants
Started: May 24, 2021 · Completed: Dec 31, 2026
4 conditions3 sponsors1 location
NCT04573231
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
PHASE2Recruiting
13 participants
Started: May 24, 2021 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT04849455
Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
PHASE4Recruiting
70 participants
Started: May 24, 2021 · Completed: May 1, 2023
4 conditions1 sponsor1 location
NCT04924569
Continence Care Registry
N/AActive, not recruiting
600 participants
Started: May 24, 2021 · Completed: May 31, 2026
2 conditions3 sponsors1 location
NCT04809025
Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer
N/ARecruiting
510 participants
Started: May 24, 2021 · Completed: Sep 1, 2026
4 conditions1 sponsor1 location
NCT04139304
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
EARLY_PHASE1Recruiting
15 participants
Started: May 24, 2021 · Completed: Jul 31, 2030
5 conditions7 sponsors8 locations
NCT05774847
Unconscious Processing in Decision-making
N/ARecruiting
200 participants
Started: May 24, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04492488
A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer
PHASE1/PHASE2Active, not recruiting
129 participants
Started: May 24, 2021 · Completed: Dec 31, 2024
3 conditions1 sponsor2 locations
NCT04741997
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
EARLY_PHASE1Recruiting
50 participants
Started: May 24, 2021 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT04774393
Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
84 participants
Started: May 24, 2021 · Completed: Nov 29, 2025
3 conditions1 sponsor1 location
NCT04349826
The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)
PHASE4Recruiting
2,150 participants
Started: May 23, 2021 · Completed: Sep 30, 2025
1 condition5 sponsors1 location
NCT04804943
Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome)
NARecruiting
45 participants
Started: May 22, 2021 · Completed: Sep 4, 2025
1 condition1 sponsor1 location
NCT04790682
LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG
NARecruiting
300 participants
Started: May 22, 2021 · Completed: Jun 3, 2030
1 condition1 sponsor3 locations
NCT05105451
Study on the Characteristics of Non-targeted Metabolomics and EEG of Delayed Neurocognitive Recovery in Elderly Patients
N/AActive, not recruiting
80 participants
Started: May 22, 2021 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT04445571
Surfactant Administration by Insure or Thin Catheter
NARecruiting
160 participants
Started: May 21, 2021 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT04722172
A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
PHASE2Active, not recruiting
55 participants
Started: May 21, 2021 · Completed: Feb 28, 2026
2 conditions3 sponsors8 locations
NCT04704934
Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)
PHASE3Active, not recruiting
490 participants
Started: May 21, 2021 · Completed: Feb 1, 2026
2 conditions2 sponsors156 locations
NCT04765137
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
PHASE2Recruiting
20 participants
Started: May 21, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04900363
A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC
PHASE1/PHASE2Active, not recruiting
108 participants
Started: May 21, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT04917796
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
NARecruiting
250 participants
Started: May 21, 2021 · Completed: Apr 24, 2026
6 conditions2 sponsors6 locations
NCT05132296
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer
NAActive, not recruiting
30 participants
Started: May 21, 2021 · Completed: Feb 2, 2027
1 condition2 sponsors2 locations
NCT04474353
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
PHASE1Active, not recruiting
12 participants
Started: May 21, 2021 · Completed: Nov 11, 2025
2 conditions2 sponsors1 location
NCT04892537
Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance
NARecruiting
50 participants
Started: May 21, 2021 · Completed: Jan 31, 2024
1 condition3 sponsors5 locations
NCT04859335
Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma
NARecruiting
50 participants
Started: May 21, 2021 · Completed: Dec 1, 2028
1 condition1 sponsor1 location
NCT04340596
Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption
PHASE1Active, not recruiting
118 participants
Started: May 21, 2021 · Completed: Dec 30, 2026
1 condition3 sponsors14 locations
NCT04362475
Community Health Through Engagement and Environmental Renewal
NAActive, not recruiting
779 participants
Started: May 21, 2021 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT05027529
ECMOsorb Trial - Impact of a VA-ECMO in Combination with CytoSorb in Critically Ill Patients with Cardiogenic Shock
NARecruiting
54 participants
Started: May 21, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05003583
Effects of Emotional Processes on Speech Motor Control in Early Childhood Stuttering.
NARecruiting
50 participants
Started: May 21, 2021 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT04877275
ATG-010(Selinexor) in Combination With Chemotherapy in RRMM
PHASE2Recruiting
50 participants
Started: May 21, 2021 · Completed: Dec 30, 2024
1 condition1 sponsor5 locations
NCT04864145
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
NARecruiting
210 participants
Started: May 21, 2021 · Completed: May 30, 2031
1 condition1 sponsor1 location
NCT04503395
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
NARecruiting
204 participants
Started: May 21, 2021 · Completed: Jun 1, 2028
1 condition2 sponsors32 locations
NCT04869280
Post-Marketing Study of Prucalopride Safety In Pregnancy
N/AActive, not recruiting
127 participants
Started: May 21, 2021 · Completed: Feb 1, 2027
1 condition2 sponsors1 location
NCT04859465
Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma
PHASE2Recruiting
69 participants
Started: May 21, 2021 · Completed: Nov 20, 2024
1 condition1 sponsor1 location
NCT04522596
Effect of Dual Bronchodilation With Umeclidinium/Vilanterol on Patients With COPD, Hyperinflation and Heart Failure
PHASE4Recruiting
60 participants
Started: May 21, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT04791735
Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular Carcinoma
NAActive, not recruiting
252 participants
Started: May 21, 2021 · Completed: May 7, 2027
1 condition1 sponsor17 locations
NCT05036330
ProvoxLife Adoption Trends for Heat-Moisture Exchanger
N/AActive, not recruiting
130 participants
Started: May 21, 2021 · Completed: Feb 2, 2027
1 condition2 sponsors1 location
NCT04837365
Impact of Neuropsychological Disorders in Multiple Sclerosis
NARecruiting
20 participants
Started: May 21, 2021 · Completed: May 31, 2026
1 condition1 sponsor3 locations
NCT05714124
Liver Embolization Approaches for Tumor Management
N/ARecruiting
580 participants
Started: May 21, 2021 · Completed: Dec 31, 2031
7 conditions1 sponsor1 location
NCT04905316
A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer
PHASE2Active, not recruiting
41 participants
Started: May 21, 2021 · Completed: May 31, 2026
1 condition2 sponsors7 locations
NCT06596252
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
PHASE3Recruiting
308 participants
Started: May 21, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor12 locations
NCT04810078
A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread
PHASE3Active, not recruiting
681 participants
Started: May 21, 2021 · Completed: May 10, 2027
1 condition1 sponsor89 locations
NCT04730544
Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.
PHASE2Active, not recruiting
96 participants
Started: May 21, 2021 · Completed: Apr 30, 2028
2 conditions2 sponsors19 locations
NCT04838210
Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care
NAEnrolling by invitation
390 participants
Started: May 21, 2021 · Completed: Jun 30, 2025
2 conditions1 sponsor4 locations
NCT05171101
The MAVEN Senior Scientist Initiative
PHASE2Enrolling by invitation
160 participants
Started: May 21, 2021 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT04370522
Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer
N/AActive, not recruiting
32 participants
Started: May 21, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor2 locations
NCT04586959
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
NARecruiting
278 participants
Started: May 21, 2021 · Completed: Oct 31, 2027
1 condition2 sponsors5 locations
NCT04995822
Post Market Clinical Follow-up of EUROSTEM Femoral Stem
N/AActive, not recruiting
131 participants
Started: May 21, 2021 · Completed: Nov 6, 2032
6 conditions1 sponsor9 locations
NCT06133933
Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid Consumption
N/AEnrolling by invitation
150 participants
Started: May 21, 2021 · Completed: May 21, 2027
3 conditions1 sponsor1 location